SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001739614-22-000012
Filing Date
2022-02-14
Accepted
2022-02-11 17:37:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13gmlfebruary2022.htm SC 13G/A 80180
  Complete submission text file 0001739614-22-000012.txt   81773
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filed by) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Subject) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91647 | Film No.: 22623061
SIC: 2836 Biological Products, (No Diagnostic Substances)